Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMED H KHAN

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1649230988
CMS profile
120135
Location
REDDING, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$34,716.94

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $30,000.00 1
Food and Beverage $3,435.17 95
Travel and Lodging $1,270.92 1
Education $10.85 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMED H KHAN

NPI 1649230988 · CMS profile ID 120135

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

REDDING, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649230988?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649230988?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649230988?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1649230988?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $34,716.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $29.3607/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141563609 CMS
Novartis Pharmaceuticals Corporation $11.4606/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087153894 CMS
PFIZER INC. $19.0706/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131678171 CMS
Abbott Laboratories $67.6406/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168332 CMS
Edwards Lifesciences Corporation $86.8306/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138775753 CMS
AstraZeneca Pharmaceuticals LP $15.6906/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105834049 CMS
Merck Sharp & Dohme LLC $29.7306/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141563507 CMS
Boston Scientific Corporation $101.7706/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092741055 CMS
Novartis Pharmaceuticals Corporation $13.6306/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087153892 CMS
Alnylam Pharmaceuticals Inc. $22.5305/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125827811 CMS
Actelion Pharmaceuticals US, Inc. $20.7905/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078871064 CMS
Boston Scientific Corporation $2.0305/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092741047 CMS
Boston Scientific Corporation $59.9505/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092741049 CMS
HEARTFLOW, INC. $13.7805/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154179542 CMS
Abbott Laboratories $29.8505/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168330 CMS
PFIZER INC. $14.2405/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131348866 CMS
Boston Scientific Corporation $134.3205/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092741057 CMS
CVRx, Inc. $135.6305/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132815659 CMS
Edwards Lifesciences Corporation $55.2905/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138775741 CMS
PFIZER INC. $12.1204/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131821824 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $50.0004/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080666651 CMS
Novartis Pharmaceuticals Corporation $13.7104/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087153890 CMS
Janssen Pharmaceuticals, Inc $30.8204/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077935860 CMS
AstraZeneca Pharmaceuticals LP $14.2004/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104779906 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.2804/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118093172 CMS
Merck Sharp & Dohme LLC $28.1104/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141911464 CMS
Lexicon Pharmaceuticals, Inc. $18.6203/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1081716288 CMS
Boston Scientific Corporation $138.2603/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092741025 CMS
PFIZER INC. $12.4903/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131805555 CMS
ShockWave Medical, Inc $19.3403/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152985076 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $60.6102/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080666615 CMS
Alnylam Pharmaceuticals Inc. $15.8102/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125827779 CMS
BIOTRONIK INC. $76.1402/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145811764 CMS
Merck Sharp & Dohme LLC $19.7602/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141563493 CMS
Abbott Laboratories $18.2702/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168328 CMS
Abbott Laboratories $82.4702/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168326 CMS
Abbott Laboratories $38.3302/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168322 CMS
Abbott Laboratories $7.1502/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168324 CMS
Medtronic, Inc. $54.3802/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119415210 CMS
Medtronic, Inc. $47.3602/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119415212 CMS
Janssen Pharmaceuticals, Inc $26.5301/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077935840 CMS
Edwards Lifesciences Corporation $189.0801/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138775723 CMS
Edwards Lifesciences Corporation $1,270.9201/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138775725 CMS
Novartis Pharmaceuticals Corporation $16.6901/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087153886 CMS
Novartis Pharmaceuticals Corporation $13.9101/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087153888 CMS
CVRx, Inc. $73.2101/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132815653 CMS
CVRx, Inc. $36.0701/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132815655 CMS
CVRx, Inc. $55.4001/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132815657 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,457.99 115
PY2020 $1,438.08 75
PY2021 $2,305.40 93
PY2022 $2,789.65 104
PY2023 $17,666.04 85
PY2024 $34,716.94 98
PY2025 $24,495.50 80

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $336,085.38 20
PY2024 Principal investigator $62,974.00 16
PY2023 Principal investigator $45,012.00 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $12,074.00 12/15/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282724
Principal investigator 1 Janssen Research & Development, LLC $2,258.00 11/21/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281552
Principal investigator 1 Janssen Research & Development, LLC $8,160.00 10/22/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282414
Principal investigator 1 Janssen Research & Development, LLC $465.00 10/09/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281539
Principal investigator 1 Janssen Research & Development, LLC $1,986.00 09/19/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281711
Principal investigator 1 Janssen Research & Development, LLC $1,085.00 09/03/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282473
Principal investigator 1 Janssen Research & Development, LLC $8,027.00 08/25/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281751
Principal investigator 1 AstraZeneca Pharmaceuticals LP $41,201.20 08/07/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC INC. DBA RESEARCH CONSULTANTS
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185550365
Principal investigator 1 Amgen Inc. $194,669.70 08/01/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246639687
Principal investigator 1 Janssen Research & Development, LLC $3,955.00 07/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282738
Principal investigator 1 Amgen Inc. $27,843.48 07/20/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC - THE CARDIOVASCULAR CENTER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246639651
Principal investigator 1 Janssen Research & Development, LLC $310.00 06/26/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281497
Principal investigator 1 Janssen Research & Development, LLC $610.00 06/25/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281796
Principal investigator 1 Janssen Research & Development, LLC $1,927.00 06/20/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282245
Principal investigator 1 Janssen Research & Development, LLC $310.00 05/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281790
Principal investigator 1 Janssen Research & Development, LLC $5,826.00 05/16/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282347
Principal investigator 1 Janssen Research & Development, LLC $3,115.00 04/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282128
Principal investigator 1 Janssen Research & Development, LLC $6,880.00 03/17/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282710
Principal investigator 1 Janssen Research & Development, LLC $13,397.00 02/24/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282393
Principal investigator 1 Janssen Research & Development, LLC $1,986.00 01/22/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282070